The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 3.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
Taiwan Semiconductor Manufacturing
TSM · NYSE (ADR) · Market cap $2.31T · 76,907 employees
Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East,…
Not yet scoredPrice as of 14 Oct 2026Daily close, not a live quoteLast reviewed 7 days ago
Screened 2026-10-14 · the tape above runs as of 13:28 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price430.00 at the 14 Oct 2026 close
- Our ratingFair value, current read markdown
- Ethical screenNot yet scored
- OptionsOpen interest leans to puts (put/call 1.27)
- Last reviewed14 Oct 2026 (7 days ago)
A summary of the dated readings below, not a live quote and not advice.
What this means: price 430.00 against the desk's fair-value range, base estimate 313.24, over the last year.
- Trend Markdown
- Insiders insiders bought, latest filing 2026-10-07
- Positioning political buying, disclosed 2026-09-22
- Options put/call open interest 1.27, read 2026-10-18
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markdown label.
Taiwan Semiconductor Manufacturing holds its Markdown at $430.00. The statistical read favours the buyers, held for 2 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the buyers, held for 2 days |
| Price at the screen | $430.00 |
| Valuation | 35.13 trailing · 23.07 forward price to earnings |
| Values screen | Not scored · score 50.0 |
| Beta | 1.26 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Taiwan Semiconductor Manufacturing clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-10-20. It updates when the underlying figures move, and past reads are kept below.
What the Numbers Say It Is WorthThe Fair Value Range
Our analysis reads FAIR VALUE: it trades above our $313.24 fair value estimate, strong competitive moat, 35.10% revenue growth.
Fair value range in , drawn from the 2026-10-14 screen. The gold marker is the market price at the same screen. The price runs 27.2% above the base estimate.
Third-party analyst targets: 18 covering, consensus None. The average target sits +8% from the screen price.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish: a quality-at-a-fair-price name rather than a deep-value one.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-14 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsWhy it is worth knowing
A quality business: a strong moat and 47% profit margins. At the screened price it sits 27% above our $313.24 fair value: priced for the quality, not a bargain.
| Forward P/E | 23.1xcheap for a company growing this fast |
| Trailing P/E | 35.1xexpensive: the price assumes strong growth ahead |
| EPS, forward | 19.29 |
| Revenue growth | +35.1%strong top-line growth |
| Profit margin | 46.5%highly profitable on every dollar of sales |
| Return on equity | 36.2%an exceptional return on shareholder capital |
| Dividend yield | 0.91% |
| Debt to equity | 0.17minimal debt: a conservative balance sheet |
| Current ratio | 2.49comfortably covers its short-term bills |
| Beta | 1.26moves a little more than the market |
| Short interest, float | 0.01% |
| 52-week range | 188.81 - 421.97 |
| Moat | STRONG |
| Market cap | $2.31T |
| Employees | 76,907 |
The risks · The things to watch: its business and earnings are exposed to Taiwan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTSM trades on NYSE (ADR) (the company is based in Taiwan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 7.2% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
The framework has shifted from accumulation to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 30% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 95%. Our forward projection puts the odds of a 10% gain over the next month near 37%. The street (18 analysts) rates it strong buy, with a mean price target of $468. It reported earnings in this window, a natural checkpoint for the thesis.
5 July 2026 — $415.17 — ACCUMULATION (state model: sideways, 282 days). Journal opened. The quiet season on the irreplaceable company: quality 92, forward 21 times, discount geopolitical not financial. Tensions on file: values pass with zero headroom at 50; insider VP raised stake 18% late June. Watch: the nine-month range edges, the screen line, fab geography.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical pass with moderate score. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-10-07 | Yuan Lipen | VP | P - Purchase | 40 | $3,176 |
| 2026-10-07 | Yeap Choh Fei | SVP | P - Purchase | 52 | $4,128 |
| 2026-10-07 | Zhang Kevin Xiaoqiang | SVP, Deputy Co-COO | P - Purchase | 59 | $4,684 |
| 2026-10-07 | Yoo Chue-San | VP | P - Purchase | 50 | $3,970 |
| 2026-10-07 | Wu Shien-Yang | SVP | P - Purchase | 53 | $4,208 |
| 2026-10-07 | Wei Che-Chia | COB, CEO | P - Purchase | 144 | $11,432 |
| 2026-10-07 | Wu Yi-Huang | VP | P - Purchase | 39 | $3,096 |
| 2026-10-07 | Wang Ying-Lang | SVP | P - Purchase | 52 | $4,128 |
| 2026-10-07 | Mii Yuh-Jier | EVP, Co-COO | P - Purchase | 68 | $5,399 |
| 2026-10-07 | Tien Bor-Zen | VP | P - Purchase | 47 | $3,731 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 2026-09-22 | Gil Cisneros | Democrat | buy | 1K–15K |
| 2026-08-25 | Michael McCaul | Republican | buy | 1K–15K |
| 2026-08-12 | Rick Allen | Republican | buy | 1K–15K |
| 2026-08-12 | Rick Allen | Republican | buy | 1K–15K |
| 2026-08-12 | Rick Allen | Republican | buy | 1K–15K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $404.54 | +1.1% | · | $1,011 | +1.1% |
| 2 months | $370.60 | +10.3% | · | $1,103 | +10.3% |
| 3 months | $335.76 | +21.8% | $0.96 | $1,221 | +22.1% |
| 6 months | $303.99 | +34.5% | $0.96 | $1,348 | +34.8% |
| 1 year | $209.86 | +94.9% | $3.39 | $1,965 | +96.5% |
| 2 years | $163.81 | +149.6% | $5.86 | $2,532 | +153.2% |
| 3 years | $98.34 | +315.8% | $7.82 | $4,237 | +323.7% |
| 5 years | $108.84 | +275.7% | $11.56 | $3,863 | +286.3% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TSM does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.